An institutional partner to the cannabis industry

Fueling the growth of businesses and management teams

About Us

We leverage a decade of hands-on experience in the cannabis industry and nearly half a century of combined institutional investing experience to help businesses capitalize on their growth potential. Our investment philosophy is straightforward: within an extremely complex industry, we seek to fund simple and proven business models that are run by best-in-class operators. This enables us to maximize risk-adjusted returns while providing management with the trust, freedom and insight to effectively run their companies.

The FocusGrowth Advantage

Disciplined Investing

$877M deployed into the cannabis industry since 2020, predominantly across senior secured credit¹
Partner with established management teams with demonstrated track records of execution
Employ private equity–style involvement with proactive engagement, requiring rigorous monthly reporting, active risk management, and frequent dialogue with management on strategic decisions

Flexible Deployment

Ability to invest across the capital structure to capture the best risk-adjusted return opportunities
Patiently await opportunities and deploy capital decisively when they arise, including secondary bond purchases and selective equity investments
Viewed as an institutional partner by operators — collaborate with management to optimize capital structures without a ‘loan-to-own’ mindset

Team Advantage

Leverage deep expertise in credit, public and private equity, special situations, and cannabis operations
Regarded as a fair, value-added partner by borrowers, operators, advisors, and co-lenders
Leverage trusted relationships, reputational strength, and historical lending track record to secure differentiated deal flow and maintain our position as a leading institutional capital provider in the industry

¹ As of Q2 2025. $877 million of capital deployed includes the total of (i) capital invested in portfolio companies by FocusGrowth, (ii) recycled capital and refinancing activities, and (iii) third-party capital not managed by FocusGrowth but deployed alongside our investment in deals where FocusGrowth was the lead or co-lead investor. Includes face value of debt investments and funded value of equity investments. FocusGrowth is not responsible for any investment decision making activities relating to the third-party capital, which is managed independently of the firm and comprises approximately $229M of the capital deployed figure above. Such assets are not included within our regulatory assets under management.

Our Team

Decades of collective years working together through credit investing and cannabis operations.

Operations Team

COO/CFO

Brendan Driscoll

Operations Team

Investor Relations

Kate Sackas

Advisory Team

Special Advisor

Jonathon Goldrath

Investment Team

Senior Associate

Luke Perda

Investment Team

Partner

Peter Bio

Investment Team

Principal

Curtis Robbins

CEO

John Lykouretzos

Investment Team

Operations Team

Controller

Steve Brusca

Jonathan Cheslock

Operations Team

Assistant Controller

Our Team

Decades of collective years working together through credit investing and cannabis operations.

John Lykouretzos

CEO

Investment Team

Peter Bio

Partner

Investment Team

Curtis Robbins

Principal

Investment Team

Luke Perda

Senior Associate

Investment Team

Brendan Driscoll

COO/CFO

Operations Team

Steve Brusca

Controller

Operations Team

Jonathan Cheslock

Assistant Controller

Operations Team

Kate Sackas

Investor Relations

Operations Team

Jonathon Goldrath

Special Advisor

Advisory Team

In the News

TerrAscend Completes $79 Million Non-Dilutive Debt Financing

TerrAscend Corp. (“TerrAscend” or the “Company”) (TSX: TSND, OTCQX: TSNDF), a leading North American cannabis company, today announced that the Company, together with certain entities that are consolidated by the Company (the “Consolidated Entities”), has closed on an upsize to its senior secured syndicated term loan (the “Loan”) of $79 million (the “Transaction”), $68 million of which were used to retire existing indebtedness across other lenders, with the remainder designated for future growth initiatives. As part of the Transaction, an additional uncommitted term loan facility in an aggregate principal amount of up to $35 million will be available for future mergers and acquisitions (“M&A”).

TerrAscend Completes $140 Million Debt Financing

TerrAscend Corp. (“TerrAscend” or the “Company”) (TSX: TSND, OTCQX: TSNDF), a leading North American cannabis company, today announced that the Company, together with certain entities that are consolidated by the Company (the “Consolidated Entities”), have closed on a senior secured term loan (the “Loan”) for gross proceeds of US$140 million (the “Transaction”) from funds managed by FocusGrowth Asset Management, LP (“FocusGrowth”), a leading capital provider to the cannabis sector, along with other members of a loan syndicate.

Standard Wellness Acquires Medical Cannabis Pharmacy in Utah

Standard Wellness Holdings is expanding its medical cannabis footprint in Utah through its acquisition of the Cannabist pharmacy.

Body & Mind Fully Repays Senior Secured Lender

Las Vegas, Nevada and Vancouver, British Columbia - (Newsfile Corp. - October 18, 2023) - Body and Mind Inc. (CSE: BAMM) (OTCQB: BMMJ) (the "Company" or "BaM"), a multi-state operations-focused cannabis company, is pleased to announce that the Company's wholly owned subsidiary, DEP Nevada, Inc. ("DEP") has closed the previously announced transaction to sell all of its interests in the Body and Mind Ohio dispensary for total consideration of US$8.225 million in cash (with an additional US$2.5 million in potential contingent proceeds - see Transaction Details below). Simultaneously with the closing of the disposition of the dispensary, the Company has fully repaid its US$7.33 million debt owing to its senior secured lender. The balance of proceeds from the disposition of the dispensary will be used to support the development of the Company's retail assets in Illinois and New Jersey.

October 18, 2023

Thinking Outside The Bud Podcast

On this episode of Thinking Outside The Bud, Host, Bruce Eckfeldt speaks with John Lykouretzos about the financing challenges facing the cannabis industry, the implications of a federally illegal market and the nuances of state controlled rules & regulation.

CannaCast Podcast: Thoughts from a Cannabis Investor

On this episode of CannaCast, Eric Altstadter, Partner and leader of EisnerAmper’s Cannabis and Hemp Group, speaks with John Lykouretzos, the Chief Executive Officer of Focus Growth Asset Management LP, an investor in the cannabis industry. The two discuss the capital needs of the industry and the experiences of a cannabis investor.

Body and Mind Extends Debt Financing

LAS VEGAS and VANCOUVER, BC, June 15, 2022 /PRNewswire/ - Body and Mind Inc. (CSE: BAMM) ( OTCQB: BMMJ) (the "Company" or "BaM"), a multi-state US cannabis operator, is pleased to provide an update on the extension and amendments to its loan agreement (the "Loan Agreement") entered into between the Company, DEP Nevada, Inc., a wholly owned subsidiary of the Company, the guarantors as set forth in the Loan Agreement, FG Agency Lending LLC (the "Agent") and Bomind Holdings LLC (the "Lender"), dated July 19, 2021, as amended on November 30, 2021.

Body and Mind Closes US$11.1 Million Debt Financing

VANCOUVER, BC, July 20, 2021 /PRNewswire/ - Body and Mind Inc. (CSE: BAMM) ( OTCQB: BMMJ) (the "Company" or "BaM"), a multi-state operator, is pleased to announce that it has closed a US$11.1 million debt financing (the "Loan") with related entities to FocusGrowth Asset Management, LP (collectively, "FGAM").

Contact

FocusGrowth Asset Management

NY Office
747 Third Avenue, Suite 3602
New York, NY 10017

investors@focusgrowth.com